AMI Lifesciences is Driven by Chemistry. Powered by People.
Reset all filters
01 2Ami Lifesciences Private Limited
02 1Lee Pharma
03 1Chunghwa Chemical Synthesis & Biotech
04 1Honour Lab Limited
05 1Alivus Life Sciences
06 3Aurisco Pharmaceutical
07 1Aurobindo Pharma Limited
08 1Beijing Hope Pharmaceutical
09 1Chengda Pharmaceuticals
10 1Divis Laboratories
11 1HEC Pharm
12 1Lupin Ltd
13 1Micro Labs Limited
14 1Optimus Pharma
15 1Solara Active Pharma Sciences
16 2Zhejiang Huahai Pharmaceutical
17 1Zhejiang Jingxin Pharmaceutical
18 1Zydus Lifesciences
Reset all filters
01 19BRIVARACETAM
02 1BRIVARACETAM (PROCESS II)
03 1BRIVARACETAM (PROCESS-II)
04 1BRIVARACETAM NON-STERILE BULK DRUG SUBSTANCE
Reset all filters
01 9China
02 12India
03 1Taiwan
Reset all filters
01 22Active
Reset all filters
01 12Complete
02 10Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 36655
Submission : 2022-01-08
Status : Active
Type : II
Lee Pharma Ltd: Global supplier of certified APIs and formulations, driven by innovation and regulatory excellence.
GDUFA
DMF Review : Complete
Rev. Date : 2025-05-28
Pay. Date : 2024-08-29
DMF Number : 39008
Submission : 2023-10-09
Status : Active
Type : II
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41491
Submission : 2025-03-31
Status : Active
Type : II
Honour is a leading global CDMO and specialty chemicals manufacturer with seven world-class sites delivering quality-driven solutions.
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-20
Pay. Date : 2020-01-30
DMF Number : 34569
Submission : 2020-02-18
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41918
Submission : 2025-05-30
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-02-19
Pay. Date : 2020-01-21
DMF Number : 34511
Submission : 2020-01-22
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-04-15
Pay. Date : 2020-03-02
DMF Number : 34398
Submission : 2020-01-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-23
Pay. Date : 2020-02-18
DMF Number : 34402
Submission : 2019-12-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-23
Pay. Date : 2020-02-19
DMF Number : 34585
Submission : 2020-02-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2020-03-23
Pay. Date : 2020-02-18
DMF Number : 34405
Submission : 2019-12-31
Status : Active
Type : II
70
PharmaCompass offers a list of Brivaracetam API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Brivaracetam manufacturer or Brivaracetam supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Brivaracetam manufacturer or Brivaracetam supplier.
PharmaCompass also assists you with knowing the Brivaracetam API Price utilized in the formulation of products. Brivaracetam API Price is not always fixed or binding as the Brivaracetam Price is obtained through a variety of data sources. The Brivaracetam Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A HY-14449 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of HY-14449, including repackagers and relabelers. The FDA regulates HY-14449 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. HY-14449 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of HY-14449 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A HY-14449 supplier is an individual or a company that provides HY-14449 active pharmaceutical ingredient (API) or HY-14449 finished formulations upon request. The HY-14449 suppliers may include HY-14449 API manufacturers, exporters, distributors and traders.
click here to find a list of HY-14449 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A HY-14449 DMF (Drug Master File) is a document detailing the whole manufacturing process of HY-14449 active pharmaceutical ingredient (API) in detail. Different forms of HY-14449 DMFs exist exist since differing nations have different regulations, such as HY-14449 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A HY-14449 DMF submitted to regulatory agencies in the US is known as a USDMF. HY-14449 USDMF includes data on HY-14449's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The HY-14449 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of HY-14449 suppliers with USDMF on PharmaCompass.
We have 18 companies offering HY-14449
Get in contact with the supplier of your choice: